Publication | Closed Access

Orally administered Endoxifen is a new therapeutic agent for breast cancer

New Therapeutic AgentBreast OncologyMedicinePharmacologyBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyTumor MicroenvironmentCancer ResearchEndocrine-related Cancer